{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T08:50:08Z","timestamp":1778575808062,"version":"3.51.4"},"reference-count":24,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,2,6]],"date-time":"2023-02-06T00:00:00Z","timestamp":1675641600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["annallergy.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of Allergy, Asthma & Immunology"],"published-print":{"date-parts":[[2023,5]]},"DOI":"10.1016\/j.anai.2023.01.027","type":"journal-article","created":{"date-parts":[[2023,2,2]],"date-time":"2023-02-02T13:59:24Z","timestamp":1675346364000},"page":"649-656.e4","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Real-world experience of pediatric patients treated with peanut (Arachis hypogaea) allergen powder-dnfp"],"prefix":"10.1016","volume":"130","author":[{"given":"Jay","family":"Portnoy","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jodi","family":"Shroba","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephen","family":"Tilles","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hela","family":"Romdhani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarah M.","family":"Donelson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dominick","family":"Latremouille-Viau","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rebecca","family":"Bungay","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kathleen","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"William","family":"McCann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.anai.2023.01.027_bib0001","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2018-1235","article-title":"The public health impact of parent-reported childhood food allergies in the United States","volume":"142","author":"Gupta","year":"2018","journal-title":"Pediatrics"},{"issue":"4","key":"10.1016\/j.anai.2023.01.027_bib0002","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.1016\/j.jaip.2020.12.020","article-title":"Characteristics of peanut allergy diagnosis in a US health care claims database (2011-2017)","volume":"9","author":"Mahr","year":"2021","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"5","key":"10.1016\/j.anai.2023.01.027_bib0003","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1111\/all.14666","article-title":"The global burden of illness of peanut allergy: a comprehensive literature review","volume":"76","author":"Lieberman","year":"2021","journal-title":"Allergy"},{"issue":"6","key":"10.1016\/j.anai.2023.01.027_bib0004","doi-asserted-by":"crossref","first-page":"2263","DOI":"10.1016\/j.jaci.2020.11.046","article-title":"Prevalence and characteristics of peanut allergy in US adults","volume":"147","author":"Warren","year":"2021","journal-title":"J Allergy Clin Immunol"},{"issue":"3","key":"10.1016\/j.anai.2023.01.027_bib0005","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/j.jaci.2022.04.008","article-title":"The natural history of peanut and egg allergy in children up to age 6 years in the HealthNuts population-based longitudinal study","volume":"150","author":"Peters","year":"2022","journal-title":"J Allergy Clin Immunol"},{"issue":"6","key":"10.1016\/j.anai.2023.01.027_bib0006","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/j.jaci.2010.10.008","article-title":"Guidelines for the diagnosis and management of food allergy in the United States: report of the NIAID-sponsored expert panel","volume":"126","author":"Boyce","year":"2010","journal-title":"J Allergy Clin Immunol"},{"issue":"6","key":"10.1016\/j.anai.2023.01.027_bib0007","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1016\/j.jaci.2020.07.031","article-title":"Peanut allergy diagnosis: a 2020 practice parameter update, systematic review, and GRADE analysis","volume":"146","author":"Greenhawt","year":"2020","journal-title":"J Allergy Clin Immunol"},{"issue":"3","key":"10.1016\/j.anai.2023.01.027_bib0008","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1007\/s40629-022-00207-8","article-title":"White paper peanut allergy","volume":"31","author":"Blumchen","year":"2022","journal-title":"Allergo J Int"},{"issue":"4","key":"10.1016\/j.anai.2023.01.027_bib0009","first-page":"516","article-title":"Economic burden of peanut allergy in pediatric patients with evidence of reactions to peanuts in the United States","volume":"27","author":"Blaiss","year":"2021","journal-title":"J Manag Care Spec Pharm"},{"issue":"4","key":"10.1016\/j.anai.2023.01.027_bib0010","doi-asserted-by":"crossref","first-page":"333","DOI":"10.2500\/aap.2021.42.210047","article-title":"Health-care resource utilization associated with peanut allergy management under allergen avoidance among commercially insured individuals","volume":"42","author":"Meadows","year":"2021","journal-title":"Allergy Asthma Proc"},{"key":"10.1016\/j.anai.2023.01.027_bib0011","unstructured":"Aimmune Therapeutics. PALFORZIA [Peanut (Arachis hypogaea) Allergen Powder-dnfp] Prescribing Information. Brisbane, CA; January 2020. https:\/\/www.palforzia.com\/sites\/default\/files\/2022-05\/pi_palforzia.pdf. Accessed January 23, 2023."},{"issue":"21","key":"10.1016\/j.anai.2023.01.027_bib0012","doi-asserted-by":"crossref","first-page":"1991","DOI":"10.1056\/NEJMoa1812856","article-title":"AR101 oral immunotherapy for peanut allergy","volume":"379","year":"2018","journal-title":"N Engl J Med"},{"issue":"10","key":"10.1016\/j.anai.2023.01.027_bib0013","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1016\/S2352-4642(20)30234-0","article-title":"Efficacy and safety of oral immunotherapy with AR101 in European children with a peanut allergy (ARTEMIS): a multicentre, double-blind, randomised, placebo-controlled phase 3 trial","volume":"4","author":"Beyer","year":"2020","journal-title":"Lancet Child Adolesc Health"},{"issue":"2","key":"10.1016\/j.anai.2023.01.027_bib0014","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1016\/j.jaip.2017.09.016","article-title":"Efficacy and safety of AR101 in oral immunotherapy for peanut allergy: results of ARC001, a randomized, double-blind, placebo-controlled phase 2 clinical trial","volume":"6","author":"Bird","year":"2018","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"1","key":"10.1016\/j.anai.2023.01.027_bib0015","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jaci.2020.11.011","article-title":"Integrating oral immunotherapy into clinical practice","volume":"147","author":"Leonard","year":"2021","journal-title":"J Allergy Clin Immunol"},{"issue":"1","key":"10.1016\/j.anai.2023.01.027_bib0016","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1186\/s13223-022-00671-5","article-title":"Eight tips for the implementation of the first licenced peanut allergy oral immunotherapy into clinical practice","volume":"18","author":"Portnoy","year":"2022","journal-title":"Allergy Asthma Clin Immunol"},{"issue":"5","key":"10.1016\/j.anai.2023.01.027_bib0017","doi-asserted-by":"crossref","first-page":"S43","DOI":"10.1016\/j.anai.2021.08.132","article-title":"Physician experience with prescribing peanut (Arachis hypogaea) allergen powder-dnfp in pediatric patients with peanut allergy","volume":"127","author":"Portnoy","year":"2021","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.anai.2023.01.027_bib0018","series-title":"Geographic levels","year":"2021"},{"issue":"6","key":"10.1016\/j.anai.2023.01.027_bib0019","doi-asserted-by":"crossref","first-page":"2043","DOI":"10.1016\/j.jaci.2021.12.780","article-title":"Safety of peanut (Arachis hypogaea) allergen powder-dnfp in children and teenagers with peanut allergy: pooled summary of phase 3 and extension trials","volume":"149","author":"Brown","year":"2022","journal-title":"J Allergy Clin Immunol"},{"issue":"3","key":"10.1016\/j.anai.2023.01.027_bib0020","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/j.anai.2021.05.023","article-title":"Antihistamine premedication improves safety and efficacy of allergen immunotherapy","volume":"127","author":"Wang","year":"2021","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"10","key":"10.1016\/j.anai.2023.01.027_bib0021","doi-asserted-by":"crossref","first-page":"3348","DOI":"10.1016\/j.jaip.2020.07.035","article-title":"AAAAI work group report: trends in oral food challenge practices among allergists in the United States","volume":"8","author":"Greiwe","year":"2020","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"1","key":"10.1016\/j.anai.2023.01.027_bib0022","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.jaip.2019.06.034","article-title":"Oral food challenge implementation: the first mixed-methods study exploring barriers and solutions","volume":"8","author":"Hsu","year":"2020","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"1","key":"10.1016\/j.anai.2023.01.027_bib0023","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/s12948-021-00153-w","article-title":"Peanut components measured by ISAC: comparison with ImmunoCap and clinical relevance in peanut allergic children","volume":"19","author":"Brand","year":"2021","journal-title":"Clin Mol Allergy"},{"issue":"4","key":"10.1016\/j.anai.2023.01.027_bib0024","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1016\/j.jaip.2021.12.022","article-title":"Real-world adoption of FDA-approved peanut oral immunotherapy with palforzia","volume":"10","author":"Patrawala","year":"2022","journal-title":"J Allergy Clin Immunol Pract"}],"container-title":["Annals of Allergy, Asthma & Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1081120623000790?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1081120623000790?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T13:31:18Z","timestamp":1761053478000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1081120623000790"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5]]},"references-count":24,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2023,5]]}},"alternative-id":["S1081120623000790"],"URL":"https:\/\/doi.org\/10.1016\/j.anai.2023.01.027","relation":{},"ISSN":["1081-1206"],"issn-type":[{"value":"1081-1206","type":"print"}],"subject":[],"published":{"date-parts":[[2023,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Real-world experience of pediatric patients treated with peanut (Arachis hypogaea) allergen powder-dnfp","name":"articletitle","label":"Article Title"},{"value":"Annals of Allergy, Asthma & Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.anai.2023.01.027","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 American College of Allergy, Asthma & Immunology. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}